• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ORISE GEL; SUBMUCOSAL INJECTION AGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ORISE GEL; SUBMUCOSAL INJECTION AGENT Back to Search Results
Model Number UNK-P-ORISE_GEL
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Muscle Spasm(s) (1966); No Consequences Or Impact To Patient (2199)
Event Date 09/01/2019
Event Type  Injury  
Manufacturer Narrative
The exact date of the event is unknown.The provided event date was chosen as a best estimate based on the date that the manufacturer became aware of the event.The complainant was unable to provide the suspect device lot number; therefore, the lot expiration and device manufacture dates are unknown.(b)(4).According to the complainant, the suspect device has been disposed and is not available for return.If any further relevant information is received, a supplemental mdr will be filed.
 
Event Description
It was reported to boston scientific corporation that orise gel was used in the ascending colon, during an endoscopic mucosal resection (emr) procedure performed on an unknown date.According to the complainant, during procedure, it was observed that when the orise gel was injected, it caused colonic spasms in the right colon.The spasms were treated using glucagon and the procedure was completed using the original orise gel.No patient complications were noted, as a result of the colonic spasms.
 
Event Description
It was reported to boston scientific corporation that orise gel was used in the ascending colon, during an endoscopic mucosal resection (emr) procedure performed on an unknown date.According to the complainant, during procedure, it was observed that when the orise gel was injected, it caused colonic spasms in the right colon.The spasms were treated using glucagon and the procedure was completed using the original orise gel.No patient complications were noted, as a result of the colonic spasms.According to the physician, the colonic spasms must have been patient related and the orise gel was unrelated to the spasms.
 
Manufacturer Narrative
B5 and h6 patient code were updated.Block b3: the exact date of the event is unknown.The provided event date was chosen as a best estimate based on the date that the manufacturer became aware of the event.Block d4 and h4: the complainant was unable to provide the suspect device lot number; therefore, the lot expiration and device manufacture dates are unknown.Block h10: according to the complainant, the suspect device has been disposed and is not available for return.If any further relevant information is received, a supplemental mdr will be filed.
 
Event Description
It was reported to boston scientific corporation that orise gel was used in the ascending colon, during an endoscopic mucosal resection (emr) procedure performed on an unknown date.According to the complainant, during procedure, it was observed that when the orise gel was injected, it caused colonic spasms in the right colon.The spasms were treated using glucagon and the procedure was completed using the original orise gel.No patient complications were noted, as a result of the colonic spasms.
 
Manufacturer Narrative
Block b3: the exact date of the event is unknown.The provided event date was chosen as a best estimate based on the date that the manufacturer became aware of the event.Block d4 and h4: the complainant was unable to provide the suspect device lot number; therefore, the lot expiration and device manufacture dates are unknown.Block h6: patient code 1966 captures the reportable event of "the orise gel caused colonic spasms" block h10: according to the complainant, the suspect device has been disposed and is not available for return.If any further relevant information is received, a supplemental mdr will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORISE GEL
Type of Device
SUBMUCOSAL INJECTION AGENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
MDR Report Key9157806
MDR Text Key161718700
Report Number3005099803-2019-04891
Device Sequence Number1
Product Code PLL
Combination Product (y/n)N
PMA/PMN Number
K180068
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 10/29/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK-P-ORISE_GEL
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/12/2019
Initial Date FDA Received10/04/2019
Supplement Dates Manufacturer Received09/12/2019
10/10/2019
Supplement Dates FDA Received10/10/2019
10/29/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-